Survivin is highly expressed in CD34+38- leukemic stem/progenitor cells and predicts poor clinical outcomes in AML

Bing Z. Carter, Yihua Qiu, Xuelin Huang, Lixia Diao, Nianxiang Zhang, Kevin R. Coombes, Duncan H. Mak, Marina Konopleva, Jorge Cortes, Hagop M. Kantarjian, Gordon B. Mills, Michael Andreeff, Steven M. Kornblau

Research output: Contribution to journal › Article › peer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Survivin is highly expressed in CD34+38- leukemic stem/progenitor cells and predicts poor clinical outcomes in AML'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds